If I recall, there were 150 million (pre-split) shares allocated as "shelf" shares that could be sold at any time. Since funds are needed for the analyzer clinical trials and other activities to bring the analyzers to market, perhaps that is how they are generating some cash. That might explain the huge swings in volume day to day with some days very active and other days (like today) absolutely dead.